Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers

Soluble E-cadherin is a 80 kDa protein fragment coming from the proteolytic cleavage of the extracellular domain of the full length epithelial cadherin, a molecule involved in cell adhesion/polarity and tissue morphogenesis. In comparison with normal epithelia, cancer cells show a decreased cadherin...

Full description

Bibliographic Details
Main Authors: Ombretta Repetto, Paolo De Paoli, Valli De Re, Vincenzo Canzonieri, Renato Cannizzaro
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2014/408047
id doaj-dba932c260254e4fb9a8e300625668d7
record_format Article
spelling doaj-dba932c260254e4fb9a8e300625668d72020-11-24T22:18:57ZengHindawi LimitedBioMed Research International2314-61332314-61412014-01-01201410.1155/2014/408047408047Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal CancersOmbretta Repetto0Paolo De Paoli1Valli De Re2Vincenzo Canzonieri3Renato Cannizzaro4Facility of Bio-Proteomics, Centro di Riferimento Oncologico (CRO), Aviano National Cancer Institute, Via F. Gallini 2, 33081 Aviano, ItalyCentro di Riferimento Oncologico (CRO), Aviano National Cancer Institute, Via F. Gallini 2, 33081 Aviano, ItalyFacility of Bio-Proteomics, Centro di Riferimento Oncologico (CRO), Aviano National Cancer Institute, Via F. Gallini 2, 33081 Aviano, ItalyPathology Unit, Centro di Riferimento Oncologico (CRO), Aviano National Cancer Institute, Via F. Gallini 2, 33081 Aviano, ItalyGastroenterology Unit, Centro di Riferimento Oncologico (CRO), Aviano National Cancer Institute, Via F. Gallini 2, 33081 Aviano, ItalySoluble E-cadherin is a 80 kDa protein fragment coming from the proteolytic cleavage of the extracellular domain of the full length epithelial cadherin, a molecule involved in cell adhesion/polarity and tissue morphogenesis. In comparison with normal epithelia, cancer cells show a decreased cadherin-mediated intercellular adhesion, and sE-cad levels normally increase in body fluids (blood and urine). This review focuses on soluble E-cadherin in sera of patients affected by three solid cancers (breast, gastric, and colorectal cancers) and how its levels correlate or not with some cancer parameters (e.g., dimension, progression, and localisation). We will describe the main proteomics approaches adopted to measure sE-cad both in vivo and in vitro and the most important findings about its behaviour in cancer dynamics.http://dx.doi.org/10.1155/2014/408047
collection DOAJ
language English
format Article
sources DOAJ
author Ombretta Repetto
Paolo De Paoli
Valli De Re
Vincenzo Canzonieri
Renato Cannizzaro
spellingShingle Ombretta Repetto
Paolo De Paoli
Valli De Re
Vincenzo Canzonieri
Renato Cannizzaro
Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
BioMed Research International
author_facet Ombretta Repetto
Paolo De Paoli
Valli De Re
Vincenzo Canzonieri
Renato Cannizzaro
author_sort Ombretta Repetto
title Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
title_short Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
title_full Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
title_fullStr Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
title_full_unstemmed Levels of Soluble E-Cadherin in Breast, Gastric, and Colorectal Cancers
title_sort levels of soluble e-cadherin in breast, gastric, and colorectal cancers
publisher Hindawi Limited
series BioMed Research International
issn 2314-6133
2314-6141
publishDate 2014-01-01
description Soluble E-cadherin is a 80 kDa protein fragment coming from the proteolytic cleavage of the extracellular domain of the full length epithelial cadherin, a molecule involved in cell adhesion/polarity and tissue morphogenesis. In comparison with normal epithelia, cancer cells show a decreased cadherin-mediated intercellular adhesion, and sE-cad levels normally increase in body fluids (blood and urine). This review focuses on soluble E-cadherin in sera of patients affected by three solid cancers (breast, gastric, and colorectal cancers) and how its levels correlate or not with some cancer parameters (e.g., dimension, progression, and localisation). We will describe the main proteomics approaches adopted to measure sE-cad both in vivo and in vitro and the most important findings about its behaviour in cancer dynamics.
url http://dx.doi.org/10.1155/2014/408047
work_keys_str_mv AT ombrettarepetto levelsofsolubleecadherininbreastgastricandcolorectalcancers
AT paolodepaoli levelsofsolubleecadherininbreastgastricandcolorectalcancers
AT vallidere levelsofsolubleecadherininbreastgastricandcolorectalcancers
AT vincenzocanzonieri levelsofsolubleecadherininbreastgastricandcolorectalcancers
AT renatocannizzaro levelsofsolubleecadherininbreastgastricandcolorectalcancers
_version_ 1725780867527213056